NEU 1.54% $15.32 neuren pharmaceuticals limited

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-211

  1. 1,211 Posts.
    lightbulb Created with Sketch. 311
    it's possible. I did ask this question following PMS phase 2 result and Jon was coy about it. They could have applied but not announced unless it's granted. I am sure they have learnt the lesson from Rett where the SP collapsed when the breakthrough application was denied.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.32
Change
-0.240(1.54%)
Mkt cap ! $1.958B
Open High Low Value Volume
$15.61 $15.93 $14.96 $8.851M 580.8K

Buyers (Bids)

No. Vol. Price($)
2 6444 $15.18
 

Sellers (Offers)

Price($) Vol. No.
$15.33 2341 1
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.